Clinical Guides
Adult Chest Infections
A clinically focused adult chest-infection guide for India that separates self-limiting bronchitis from pneumonia, tuberculosis, influenza, COVID-19 and aspiration while prioritising severity, imaging, microbiology, oxygen, sepsis care, pleural complications and antimicrobial stewardship.
MedNext Academy | 13 min read
Adult Chest Infections
A clinically focused adult chest-infection guide for India that separates self-limiting bronchitis from pneumonia, tuberculosis, influenza, COVID-19 and aspiration while prioritising severity, imaging, microbiology, oxygen, sepsis care, pleural complications and antimicrobial stewardship.
Summary
Adult chest infection is a presentation, not a final diagnosis. Acute cough with fever, sputum, breathlessness or chest discomfort may reflect viral bronchitis, community-acquired pneumonia, influenza, COVID-19, tuberculosis, aspiration, an exacerbation of chronic lung disease or a non-infective mimic. The immediate task is to identify physiological compromise and focal lung disease while avoiding antibiotics for uncomplicated viral bronchitis. Community-acquired pneumonia is diagnosed clinically in the community and generally confirmed with chest imaging in hospital. Hospital-acquired and ventilator-associated infections are separate pathways with different organisms and resistance risks.
Assess airway, breathing, circulation, mental state and oxygen saturation before an extended history. Pneumonia severity tools such as CRB65 or CURB65 can support but never replace judgement; hypoxaemia, sepsis, rapid deterioration, frailty, pregnancy, immunosuppression and poor home support may justify escalation at a nominally low score. Obtain appropriate microbiology before antibiotics in severe disease when this does not delay treatment. Narrow, switch intravenous to oral and stop according to diagnosis, response and current local guidance.
India-specific practice must keep pulmonary tuberculosis in the differential when cough is persistent, constitutional symptoms or exposure are present, imaging is suggestive, or response is atypical. Uncritical fluoroquinolone use can partially suppress TB and promote resistance. Oxygen is a drug with a documented target, not a substitute for treating shock or respiratory failure. This draft does not provide a personal prescription and remains quarantined following MedNext Clinical Team review.
How Common Is It?
Acute respiratory infections are common, but the proportion caused by bacterial pneumonia varies by season, age, vaccination, comorbidity, setting and the threshold for imaging. Most otherwise healthy adults with a short cough syndrome have viral infection or acute bronchitis rather than bacterial pneumonia. Conversely, pneumonia remains an important cause of hospital admission and death, especially in older adults, people with chronic lung, cardiac, renal or liver disease, diabetes, frailty, harmful alcohol use or immunosuppression. COVID-19 and influenza change the seasonal case mix, while tuberculosis contributes a major chronic respiratory burden in India.
A single national percentage is misleading because outpatient syndromic diagnoses, radiographically confirmed pneumonia and microbiologically proven infections measure different populations. Hospital data overrepresent severe disease and local resistance; community surveys may miss people unable to access care. The ICMR guidance therefore emphasizes clinical diagnosis, pathogen prediction, microbiology and stewardship rather than treating every fever or cough as bacterial infection. Local antibiograms are most informative when stratified by specimen quality, ward, acquisition setting and patient population.
Service burden includes repeat visits, unnecessary imaging, inappropriate antibiotics, delayed TB diagnosis, oxygen demand and pleural procedures. Audit should separate acute bronchitis, community-acquired pneumonia, aspiration, hospital-acquired pneumonia and confirmed viral disease. Useful measures include time to severity assessment, proportion imaged when indicated, cultures obtained before broad therapy in severe cases, antibiotic review at 48 to 72 hours, intravenous-to-oral switching, excess duration, TB testing when clinically indicated, and readmission or complication rates.
Risk Factors
For community-acquired pneumonia, risk rises with advanced age, frailty, smoking, harmful alcohol use, chronic obstructive pulmonary disease, bronchiectasis, asthma with severe disease or systemic steroid exposure, heart failure, diabetes, chronic kidney or liver disease, malnutrition and impaired immunity. Recent influenza can precede bacterial pneumonia. Recent healthcare contact, antibiotics, hospitalisation or residence in a long-term-care facility changes the probability of resistant organisms but should not automatically trigger the broadest regimen. Previous microbiology, structural lung disease and current illness severity are more useful than a single healthcare-associated label.
Aspiration risk deserves explicit assessment. Reduced consciousness, stroke, neurodegenerative disease, dysphagia, seizures, vomiting, reflux, poor dentition, sedating medicines, alcohol intoxication, tube feeding and unsafe positioning can allow oropharyngeal or gastric material to enter the lung. Aspiration pneumonitis is chemical injury and may not require antibiotics initially; aspiration pneumonia is infection, often after an evolving clinical course. Distinguishing them prevents reflex antimicrobial use while ensuring deteriorating patients are reassessed.
Tuberculosis risk includes close exposure, previous TB or incomplete treatment, HIV, immunosuppressive therapy, undernutrition, silicosis, diabetes, smoking, crowded living or institutional settings and migration from high-burden areas. Influenza and severe COVID-19 risks overlap with age, pregnancy, obesity, cardiorespiratory disease and immunosuppression. For hospital-acquired infection, ventilation, impaired airway clearance, prolonged admission and broad antibiotic exposure matter. Risk factors guide testing and setting; they do not identify a pathogen reliably enough to bypass examination, imaging or cultures when those are indicated.
Diagnosis
History
Clarify onset, duration and trajectory of cough, sputum, fever, rigors, breathlessness, wheeze, pleuritic pain, haemoptysis, confusion, vomiting and oral intake. Ask about sick contacts, influenza or COVID circulation, vaccination, travel, aspiration or choking, tuberculosis exposure, weight loss and night sweats. Document chronic lung and cardiac disease, diabetes, renal and liver function, pregnancy, immune status, smoking, alcohol, recent hospitalisation, antibiotics, previous resistant organisms, drug allergy and baseline function. A cough persisting beyond the expected acute course or failing treatment needs diagnostic review, not repeated empiric antibiotics.
Examination
Record temperature, respiratory rate, pulse, blood pressure, oxygen saturation, mental state, hydration and work of breathing. Look for cyanosis, inability to speak, exhaustion, accessory-muscle use, sepsis, focal crackles, bronchial breathing, dullness, reduced air entry, wheeze, calf asymmetry, heart failure and aspiration clues. Older or immunosuppressed adults may lack fever. Calculate CRB65 or CURB65 where applicable but treat hypotension, hypoxaemia, confusion or rapid decline as important independently.
Investigations
In hospital, obtain chest radiography promptly to confirm and define pneumonia; consider lung ultrasound or CT when the film is inconclusive, complications are suspected or an alternative diagnosis remains likely. Use full blood count, renal and liver tests, glucose, lactate, blood gas and inflammatory markers according to severity. Send sputum and blood cultures in severe disease or when resistant or unusual pathogens are possible, ideally before antibiotics without delaying urgent treatment. Test for influenza, SARS-CoV-2, HIV or TB according to epidemiology and phenotype. Pleural fluid requires diagnostic sampling when significant effusion or infection is suspected.
Differential Diagnosis
Acute bronchitis usually causes cough, sometimes sputum or wheeze, without focal consolidation or physiological severity; sputum colour alone does not prove bacterial infection. Pneumonia is more likely with focal chest signs, tachypnoea, hypoxaemia, systemic illness or a new infiltrate. Influenza often produces abrupt fever, myalgia, headache and cough, while COVID-19 spans mild upper-respiratory illness to viral pneumonia; neither clinical pattern is perfectly specific. Secondary bacterial infection is considered when a person deteriorates after initial viral improvement or develops focal consolidation, but antibiotics do not treat uncomplicated viral disease.
Pulmonary tuberculosis may present subacutely with cough, fever, night sweats, weight loss, haemoptysis, lymphadenopathy, pleural effusion or atypical imaging. It can also be acute or coexist with bacterial pneumonia. Follow current NTEP molecular and microbiological pathways rather than relying on a therapeutic antibiotic trial. Aspiration pneumonitis follows a witnessed or strongly suspected aspiration with rapid chemical inflammation; aspiration pneumonia is an infective syndrome that may evolve later. Lung abscess and empyema are suppurative complications needing imaging, prolonged targeted therapy and often drainage.
Non-infective mimics include pulmonary embolism, acute heart failure or oedema, acute coronary syndrome, pneumothorax, malignancy, interstitial lung disease, eosinophilic lung disease, drug toxicity, vasculitis and diffuse alveolar haemorrhage. COPD or asthma exacerbation may be viral and need airway treatment rather than antibiotics unless bacterial criteria are met. Persistent focal pneumonia raises obstruction by tumour or foreign body. Diagnostic anchoring is dangerous: pleuritic pain and fever do not exclude embolism, and a chest radiograph abnormality must be interpreted with timing and clinical context.
Management
Stabilise first. Position the patient, provide controlled oxygen to an individualized target, establish monitoring and venous access when illness is severe, measure lactate when sepsis is suspected, and begin the local sepsis pathway for shock or organ dysfunction. Escalate respiratory support when hypoxaemia or work of breathing persists; non-invasive support is not appropriate for every cause or patient and must be monitored where intubation can occur if needed. Give fluids carefully, considering heart and kidney failure. Analgesia, antipyresis, hydration, nutrition, mobilization and thrombosis prevention are supportive components, not afterthoughts.
For uncomplicated acute bronchitis, explain the expected cough course, offer simple supportive measures and avoid antibiotics. For pneumonia, use severity, acquisition setting, comorbidity, aspiration risk, previous microbiology and local resistance to choose an empiric regimen. Obtain cultures in severe disease, then review clinical response and results at 48 to 72 hours. Narrow therapy, switch intravenous to oral when stable and use the shortest effective current guideline course. Failure to improve should prompt re-evaluation for empyema, abscess, resistant or unusual pathogen, TB, obstruction, aspiration or a non-infective diagnosis rather than automatic escalation.
Pleural infection requires ultrasound-guided assessment, pleural fluid analysis, drainage when indicated and respiratory or surgical involvement. Influenza antiviral and COVID-specific treatment follow current national or institutional criteria, timing and contraindications; evidence and circulating variants change. Aspiration management includes airway protection, swallowing assessment, positioning and oral care. Arrange smoking cessation, indicated vaccination and follow-up. Repeat imaging is selective, especially for persistent symptoms or risk of underlying malignancy, not an automatic ritual for every recovered young adult.
Prescribing Information
Antibiotics should be prescribed for a supported bacterial syndrome, not for sputum colour, fever alone or patient expectation. Before the first dose, record diagnosis, acquisition setting, severity, allergy and reaction, pregnancy, renal and hepatic function, recent antibiotic exposure, previous resistant isolates and microbiology obtained. The ICMR 2022 guidance provides Indian syndrome-based options, but a static web guide cannot safely override a current hospital policy or antibiogram. Community, ward, intensive-care, aspiration and hospital-acquired regimens are not interchangeable. Reserve anti-pseudomonal, anti-MRSA and carbapenem therapy for defined risks and de-escalate when evidence permits.
Avoid indiscriminate fluoroquinolone use, particularly where tuberculosis is plausible, because partial clinical response can delay TB diagnosis and exposure selects resistance. Macrolides prolong QT and interact with other medicines; beta-lactams require accurate allergy assessment; aminoglycosides require renal and drug-level safeguards; tetracyclines and other agents have pregnancy and age restrictions. Adjust doses for renal function and body size. Document route, interval, indication, review date and intended duration. Intravenous therapy is not inherently superior once the patient is clinically stable and absorbing oral medicines.
Do not prescribe antibiotics for uncomplicated acute bronchitis, influenza or COVID-19 without evidence of bacterial coinfection. Antivirals are time-sensitive and indication-specific; verify current national or institutional guidance rather than copying an old pandemic schedule. Oxygen requires a target and monitoring; people at risk of hypercapnic respiratory failure need controlled therapy and blood-gas assessment. Steroids are not routine for every chest infection: use only for a supported indication such as a relevant airway exacerbation or current high-severity pneumonia protocol. Reconcile medicines and provide safety-netting; this section is educational, not a personal prescription.
When to Refer
Arrange emergency hospital assessment for severe breathlessness, central cyanosis, persistent hypoxaemia, confusion, systolic hypotension, shock, inability to maintain oral intake, haemoptysis of concern, rapidly worsening illness or sepsis. Respiratory rate, oxygen requirement and overall trajectory matter even when a formal score is low. Consider a lower threshold for frailty, pregnancy, immunosuppression, major cardiorespiratory disease, renal or liver failure, unreliable follow-up or long travel to care. Provide stabilization and an appropriately monitored transfer rather than asking an unstable patient to travel unassisted.
Refer or admit pneumonia when CRB65 or CURB65 and clinical judgement indicate moderate or high risk, or when outpatient treatment is unsafe. Escalate within hospital for rising oxygen need, hypercapnia, exhaustion, acidosis, haemodynamic instability, multilobar disease or organ dysfunction. Involve respiratory medicine for significant effusion, suspected empyema, lung abscess, recurrent focal pneumonia, non-resolving infiltrate or diagnostic uncertainty; pleural infection may need urgent drainage and thoracic surgical discussion. Intensive care review should occur before irreversible fatigue or shock.
Refer to NTEP-linked TB services when symptoms, exposure, imaging or microbiology suggest tuberculosis; use airborne precautions according to local protocol. Infectious-disease or microbiology advice is appropriate for severe immune compromise, unusual exposure, treatment failure or multidrug-resistant organisms. Arrange swallowing assessment after recurrent aspiration, stroke or bulbar symptoms. Follow-up is needed for persistent cough, fever, weight loss, haemoptysis or functional decline. State the actual destination, urgency, transport, pending results and antimicrobials given in every referral.
Red Flags
Immediate threats include inability to speak because of breathlessness, central cyanosis, severe hypoxaemia, silent or markedly reduced air entry, exhaustion, altered consciousness, respiratory arrest, systolic hypotension, mottled skin, oliguria or a rising lactate. A falling respiratory rate is not reassuring when mental state or effort deteriorates; it may signal fatigue. Suspected sepsis requires urgent assessment and source control, cultures where feasible and timely antimicrobials. Oxygen requirement that rises despite treatment, new hypercapnia or acidosis warrants senior and critical-care review.
Pleuritic pain with sudden dyspnoea, haemoptysis, syncope or unilateral leg swelling may indicate pulmonary embolism. Sudden unilateral absent breath sounds suggests pneumothorax. Crushing chest pain, diaphoresis or haemodynamic instability requires acute coronary evaluation. Pink frothy sputum, raised jugular pressure and diffuse crackles may indicate pulmonary oedema. These diagnoses may coexist with infection, so a fever or infiltrate does not end diagnostic reasoning.
Complication red flags are persistent fever, recurrent rigors, worsening after 48 to 72 hours, a new pleural collection, severe localized chest pain, cavitation, putrid sputum or bacteraemia. Persistent cough, night sweats, weight loss, haemoptysis, upper-lobe or cavitary change and close TB exposure need prompt tuberculosis testing and infection-control consideration. After aspiration, stridor, airway obstruction, reduced consciousness or rapidly progressing hypoxaemia is an emergency. Immunosuppressed patients may deteriorate without fever or leukocytosis. Discharge advice must name worsening breathlessness, confusion, cyanosis, inability to drink, reduced urine, haemoptysis and failure to improve as reasons for urgent reassessment.
Indian Clinical Context
In India, empiric pneumonia treatment must be reconciled with ICMR syndrome guidance, the facility antibiogram and the patient's previous microbiology. Resistance varies across hospitals and regions; a tertiary intensive-care antibiogram should not be applied directly to uncomplicated community cases. Obtain good-quality specimens in severe disease, avoid treating colonization and review every broad prescription. Antibiotics sold without structured reassessment, repeated injections for viral cough and combinations containing unnecessary agents increase cost, adverse effects and resistance without improving diagnosis.
Tuberculosis must remain visible. Persistent cough, constitutional symptoms, relevant exposure, haemoptysis, pleural effusion, cavitation or failure of ordinary treatment warrants NTEP-aligned testing, including recommended molecular assays and drug-resistance assessment. Do not use a nonspecific antibiotic response to exclude TB. Fluoroquinolones can transiently improve symptoms and delay recognition. Follow local infection-control and notification requirements, and arrange linkage to public or approved services rather than leaving the patient with an isolated test result.
Access to radiography, microbiology, viral testing, oxygen, ultrasound and intensive care is uneven. When resources are constrained, prioritize physiological severity, pulse oximetry with awareness of measurement limitations, basic imaging where it will change care, timely referral and reassessment. Biomass smoke, tobacco exposure, overcrowding, undernutrition and delayed presentation influence risk and recovery. Ask about medicine affordability, transport and the ability to return. COVID-19 and influenza recommendations change with surveillance and available treatments; use current Ministry or institutional advice rather than embedding an obsolete pandemic regimen. Clear bilingual instructions and a named review plan are essential.
NMC Competency Mapping
Adult lower-respiratory infection integrates multiple NMC CBME outcomes. General Medicine competencies in the respiratory infection domain require learners to describe pneumonia aetiology and clinical features, develop a diagnosis and severity assessment, select investigations and formulate management under supervision. Tuberculosis competencies require epidemiology, clinical recognition, microbiological diagnosis, treatment principles, public-health responsibilities and prevention. Microbiology competencies MI6.1 to MI6.3 cover respiratory pathogens, appropriate specimen collection and interpretation, while pharmacology and AETCOM outcomes support rational antimicrobial use, consent and communication.
At the bedside, a learner should take a structured cough and dyspnoea history, identify aspiration and TB risks, measure respiratory rate and saturation, assess haemodynamics and mental state, perform a focused respiratory examination and recognize sepsis. The student should distinguish acute bronchitis from pneumonia and non-infective mimics, interpret chest radiography and basic laboratory data, know when sputum, blood culture, viral or TB testing is justified, and apply CRB65 or CURB65 without surrendering clinical judgement to the score.
Management competence includes controlled oxygen, appropriate escalation, supportive care, safe specimen collection, empiric-to-targeted antibiotic reasoning and a documented 48-to-72-hour review. Students must not independently prescribe complex regimens beyond their level of supervision. Assessment should reward stopping antibiotics in viral bronchitis, considering TB before fluoroquinolone exposure, detecting pleural infection and communicating red flags. Integration spans medicine, microbiology, pharmacology, radiology, critical care and public health.
Key Exam Pearls for NEET PG
Acute bronchitis is usually viral, and purulent-looking sputum does not by itself justify an antibiotic. Community-acquired pneumonia is suggested by acute lower-respiratory symptoms with focal signs or physiological disturbance and is generally confirmed by a new infiltrate in hospital. Streptococcus pneumoniae remains a classic cause, but pathogen prediction is imperfect; atypical organisms, influenza and post-viral bacterial infection remain relevant. Hospital-acquired pneumonia begins after admission and has a different resistance context. Aspiration pneumonitis is chemical injury after aspiration, whereas aspiration pneumonia is an infective syndrome; neither label should be assigned solely from a dependent-lobe opacity.
CRB65 uses confusion, respiratory rate at least 30, low blood pressure and age at least 65; CURB65 adds blood urea. Scores support site-of-care decisions but do not capture hypoxaemia, frailty, immune compromise or social safety. Obtain chest imaging in hospital, and use microbiology selectively but more aggressively in severe disease. A parapneumonic effusion that is infected requires drainage as well as antibiotics; failure to improve suggests empyema, abscess, obstruction, TB, resistance or a non-infective mimic.
Treat severe hypoxaemia and sepsis immediately. Oxygen has an individualized target, especially where hypercapnic respiratory failure is possible. Review antibiotics at 48 to 72 hours, narrow to culture results, switch intravenous to oral when stable and avoid excess duration. Do not give antibiotics for uncomplicated influenza or COVID-19 without bacterial evidence. In India, persistent cough, night sweats, weight loss, haemoptysis or cavitation demands TB evaluation; empiric fluoroquinolone exposure can mask tuberculosis and select resistance.
Frequently Asked Questions
Does green or yellow sputum mean an adult definitely needs antibiotics?
No. Sputum colour reflects inflammatory cells and can occur in viral bronchitis as well as bacterial infection. Antibiotic decisions should use the whole syndrome: physiological severity, focal chest findings, imaging when indicated, comorbidity and likely diagnosis. Breathlessness, hypoxaemia, confusion, hypotension or a new infiltrate deserves urgent assessment; colour alone is not a prescribing test.
When should tuberculosis be considered instead of ordinary pneumonia?
Consider TB with persistent or recurrent cough, weight loss, night sweats, haemoptysis, close exposure, previous TB, HIV or immunosuppression, upper-lobe or cavitary imaging, pleural effusion, or failure to improve as expected. TB can present acutely or coexist with bacterial pneumonia. Use current NTEP molecular and microbiological pathways rather than an antibiotic trial to exclude it.
Why might a patient worsen despite starting an apparently appropriate antibiotic?
Possible reasons include the wrong diagnosis, delayed response, resistant or unusual pathogen, inadequate absorption or dosing, empyema, lung abscess, obstruction, aspiration, tuberculosis, immune compromise or a non-infective mimic such as embolism or heart failure. Deterioration requires renewed examination, imaging and microbiological review, not automatic addition of progressively broader antibiotics.
Which chest-infection symptoms require emergency assessment rather than home review?
Severe or rapidly worsening breathlessness, blue lips or tongue, confusion, collapse, inability to drink, very low urine output, low blood pressure, persistent low oxygen saturation, significant haemoptysis, severe chest pain, exhaustion or reduced responsiveness needs emergency assessment. People who are frail, pregnant, immunosuppressed or far from care may need earlier escalation even with less dramatic symptoms.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic